Yi-qi-hua-yu-jie-du decoction induces ferroptosis in cisplatin-resistant gastric cancer via the AKT/GSK38/NRF2/GPX4 axis

被引:30
作者
Huang, Wenjie [1 ,2 ]
Wen, Fang [3 ,4 ]
Yang, Peipei [1 ,2 ]
Li, Ye [1 ,2 ]
Li, Qiurong [1 ,2 ]
Shu, Peng [1 ,2 ,5 ]
机构
[1] Nanjing Univ Chinese Med, Affiliated Hosp, Nanjing, Jiangsu 210029, Peoples R China
[2] Nanjing Univ Chinese Med, Sch Clin Med 1, Nanjing, Jiangsu 210023, Peoples R China
[3] Nanjing Univ Chinese Med, Sch Chinese Med, Nanjing, Jiangsu 210023, Peoples R China
[4] Nanjing Univ Chinese Med, Sch Integrated Chinese & Western Med, Nanjing, Jiangsu 210023, Peoples R China
[5] Nanjing Univ Chinese Med, Affiliated Hosp, 155 Hanzhong Rd, Nanjing, Jiangsu, Peoples R China
关键词
Gastric cancer; Drug resistance; Ferroptosis; Traditional Chinese medicine; GPX4; IDENTIFICATION; CELLS; GPX4;
D O I
10.1016/j.phymed.2023.155220
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: Resistance to chemotherapy in gastric cancer (GC) is a ubiquitous challenge for its treatment. Yi-qi-hua-yu-jie-du decoction (YJD), an empirical formula in Traditional Chinese Medicine (TCM), demonstrated survival-prolonging functions in patients with GC. Previous research has shown that YJD could also inhibit drug resistance in GC. However, the precise mechanisms for how YJD accomplishes this remain incompletely explained. Purpose: The research aimed to identify differential metabolic characteristics in cisplatin-resistant GC and investigate whether YJD can target these differences to suppress GC drug resistance. Methods: Metabolomic analysis was conducted to identify metabolic disparities between cisplatin-resistant and parental GC cells, as well as metabolic modifications resulting from YJD intervention in cisplatin-resistant GC cells. The effect of YJD on ferroptosis stimulation was assessed by measuring the levels of reactive oxygen species (ROS), malondialdehyde (MDA), iron ions, the reduced glutathione (GSH) to oxidised glutathione (GSSG) ratio, and alterations in mitochondrial morphology. Western blotting and quantitative real-time polymerase chain reaction (Q-PCR) were employed to verity the mechanisms of YJD-triggered ferroptosis through GPX4 and NRF2 overexpression models, alongside the AKT activator SC79. In vivo validation was conducted using nude mouse xenograft models. Results: Cisplatin-resistant GC exhibited altered GSH/GPX4 metabolism, and ferroptosis was a significantly enriched cell death pattern with YJD treatment in cisplatin-resistant GC cells. Ferroptosis biomarkers, including ROS, MDA, iron ions, the GSH/GSSG ratio, and mitochondrial morphology, were remarkably changed with the YJD intervention. Mechanistic experiments demonstrated that YJD inhibited the phosphorylation cascade activity of the AKT/GSK38 pathway, thereby reducing NRF2 expression. The level of GPX4, a crucial enzyme involved in glutathione metabolism, was attenuated, facilitating ferroptosis induction in cisplatin-resistant GC. Conclusion: The research reveals, for the first time, changes in GSH/GPX4 metabolism in cisplatin-resistant GC cells based on metabolomic analysis. YJD induced ferroptosis in cisplatin-resistant GC by inhibiting GPX4 through the AKT/GSK38/NRF2 pathway, thus attenuating the cisplatin drug resistance in GC. Our findings identify metabolic changes in cisplatin-resistant GC and establish a theoretical framework for YJD on tackling drug resistance in GC through ferroptosis.
引用
收藏
页数:17
相关论文
共 57 条
[1]   Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion [J].
Angeli, Jose Pedro Friedmann ;
Krysko, Dmitri, V ;
Conrad, Marcus .
NATURE REVIEWS CANCER, 2019, 19 (07) :405-414
[2]   Ferulic Acid Mitigates Growth and Invasion of Esophageal Squamous Cell Carcinoma through Inducing Ferroptotic Cell Death [J].
Cao, Yu ;
Zhang, Hong ;
Tang, Jianming ;
Wang, Rui .
DISEASE MARKERS, 2022, 2022
[3]   Phyto-sesquiterpene lactones DET and DETD-35 induce ferroptosis in vemurafenib sensitive and resistant melanoma via GPX4 inhibition and metabolic reprogramming [J].
Chang, Meng-Ting ;
Tsai, Li-Chu ;
Nakagawa-Goto, Kyoko ;
Lee, Kuo-Hsiung ;
Shyur, Lie-Fen .
PHARMACOLOGICAL RESEARCH, 2022, 178
[4]   Discovery of Novel Potent Covalent Glutathione Peroxidase 4 Inhibitors as Highly Selective Ferroptosis Inducers for the Treatment of Triple-Negative Breast Cancer [J].
Chen, Tingting ;
Leng, Jiafu ;
Tan, Jun ;
Zhao, Yongjun ;
Xie, Shanshan ;
Zhao, Shifang ;
Yan, Xiangyu ;
Zhu, Liqiao ;
Luo, Jun ;
Kong, Lingyi ;
Yin, Yong .
JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (14) :10036-10059
[5]   AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis [J].
Chen, Tzu-Chi ;
Chuang, Jian-Ying ;
Ko, Chiung-Yuan ;
Kao, Tzu-Jen ;
Yang, Pei-Yu ;
Yu, Chun-Hui ;
Liu, Ming-Sheng ;
Hu, Siou-Lian ;
Tsai, Yu-Ting ;
Chan, Hardy ;
Chang, Wen-Chang ;
Hsu, Tsung-, I .
REDOX BIOLOGY, 2020, 30
[6]   NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis [J].
Dodson, Matthew ;
Castro-Portuguez, Raul ;
Zhang, Donna D. .
REDOX BIOLOGY, 2019, 23
[7]   Nobiletin Induces Ferroptosis in Human Skin Melanoma Cells Through the GSK3β-Mediated Keap1/Nrf2/HO-1 Signalling Pathway [J].
Feng, Senling ;
Zhou, Yongheng ;
Huang, Hongliang ;
Lin, Ying ;
Zeng, Yifeng ;
Han, Shanshan ;
Huang, Kaikai ;
Liu, Quanzhi ;
Zhu, Wenting ;
Yuan, Zhongwen ;
Liang, Baoying .
FRONTIERS IN GENETICS, 2022, 13
[8]   Targeting oxidative stress in disease: promise and limitations of antioxidant therapy [J].
Forman, Henry Jay ;
Zhang, Hongqiao .
NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (09) :689-709
[9]   Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling [J].
Fu, Dazhi ;
Wang, Chunxiao ;
Yu, Lei ;
Yu, Rui .
CELLULAR & MOLECULAR BIOLOGY LETTERS, 2021, 26 (01)
[10]   Reactive oxygen species and cancer paradox: To promote or to suppress? [J].
Galadari, Sehamuddin ;
Rahman, Anees ;
Pallichankandy, Siraj ;
Thayyullathil, Faisal .
FREE RADICAL BIOLOGY AND MEDICINE, 2017, 104 :144-164